Skip to content
CompletedPhase 2 / Phase 3

Lamotrigine for Ketamine Dependence Trial

NCT02556060 · Taipei City Hospital

Closed to entry
Status
Not accepting participants
Phase 2 / Phase 3
Phase
30
Target enrolment
1
Study sites
Outside the US

What it is testing

Summary

The purpose of this study is to investigate the efficacy of lamotrigine in the treatment of ketamine dependence in a double-blind, placebo controlled design.

Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.

What counts as success

Primary outcome measures

  • Urine drug screen

    Measured over 12 weeks

A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.

Who can take part

Eligibility, as published

18 Years to 65 Years
Ages
All
Sex
Not accepted
Healthy volunteers
Inclusion Criteria: 1. Current users of ketamine, including having a ketamine-positive urine 2. Meeting DSM-5 criteria for ketamine use disorder 3. Age between 18 to 65 years old 4. Women of childbearing age must have a negative pregnancy test to enroll in this study, agree to monthly pregnancy testing, and agree to use appropriate forms of birth control for the duration of the study. Exclusion Criteria: 1. Significant medical conditions such as abnormal liver function or renal function confirmed by laboratory tests 2. Hypertension 3. A current cardiac condition or high risk of cardiovascular disease 4. Seizure disorders 5. Any another significant underlying medical condition which would contraindicate lamotrigine treatment 6. Meeting DSM-IV psychiatric classifications for schizophrenia, bipolar disorder, or other psychotic disorders 7. Meeting DSM-IV psychiatric classifications for substance use disorder other than ketamine within three month except tobacco or caffeine. 8. Exhibiting current suicidality or homicidality 9. Pregnant women, lactating women or women who are planning to be pregnant.

Where

1 study site

FacilityCityRegionCountry
Taipei City Hospital and Psychiatric CenterTaipeiTaiwan

On the registry

Contact the trial directly

This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.

Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.

NCT02556060 on ClinicalTrials.gov →

Last updated in the registry 2018-02-01. Registry records change; this page reflects the data build of 2026-08-25.

Related

Where this trial sits

Substance

Indication